#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Interferon Regulatory Factor-1 (IRF-1) Shapes Both Innate and CD8 T Cell Immune Responses against West Nile Virus Infection


Interferon regulatory factor (IRF)-1 is an immunomodulatory transcription factor that functions downstream of pathogen recognition receptor signaling and has been implicated as a regulator of type I interferon (IFN)-αβ expression and the immune response to virus infections. However, this role for IRF-1 remains controversial because altered type I IFN responses have not been systemically observed in IRF-1-/- mice. To evaluate the relationship of IRF-1 and immune regulation, we assessed West Nile virus (WNV) infectivity and the host response in IRF-1-/- cells and mice. IRF-1-/- mice were highly vulnerable to WNV infection with enhanced viral replication in peripheral tissues and rapid dissemination into the central nervous system. Ex vivo analysis revealed a cell-type specific antiviral role as IRF-1-/- macrophages supported enhanced WNV replication but infection was unaltered in IRF-1-/- fibroblasts. IRF-1 also had an independent and paradoxical effect on CD8+ T cell expansion. Although markedly fewer CD8+ T cells were observed in naïve animals as described previously, remarkably, IRF-1-/- mice rapidly expanded their pool of WNV-specific cytolytic CD8+ T cells. Adoptive transfer and in vitro proliferation experiments established both cell-intrinsic and cell-extrinsic effects of IRF-1 on the expansion of CD8+ T cells. Thus, IRF-1 restricts WNV infection by modulating the expression of innate antiviral effector molecules while shaping the antigen-specific CD8+ T cell response.


Vyšlo v časopise: Interferon Regulatory Factor-1 (IRF-1) Shapes Both Innate and CD8 T Cell Immune Responses against West Nile Virus Infection. PLoS Pathog 7(9): e32767. doi:10.1371/journal.ppat.1002230
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.ppat.1002230

Souhrn

Interferon regulatory factor (IRF)-1 is an immunomodulatory transcription factor that functions downstream of pathogen recognition receptor signaling and has been implicated as a regulator of type I interferon (IFN)-αβ expression and the immune response to virus infections. However, this role for IRF-1 remains controversial because altered type I IFN responses have not been systemically observed in IRF-1-/- mice. To evaluate the relationship of IRF-1 and immune regulation, we assessed West Nile virus (WNV) infectivity and the host response in IRF-1-/- cells and mice. IRF-1-/- mice were highly vulnerable to WNV infection with enhanced viral replication in peripheral tissues and rapid dissemination into the central nervous system. Ex vivo analysis revealed a cell-type specific antiviral role as IRF-1-/- macrophages supported enhanced WNV replication but infection was unaltered in IRF-1-/- fibroblasts. IRF-1 also had an independent and paradoxical effect on CD8+ T cell expansion. Although markedly fewer CD8+ T cells were observed in naïve animals as described previously, remarkably, IRF-1-/- mice rapidly expanded their pool of WNV-specific cytolytic CD8+ T cells. Adoptive transfer and in vitro proliferation experiments established both cell-intrinsic and cell-extrinsic effects of IRF-1 on the expansion of CD8+ T cells. Thus, IRF-1 restricts WNV infection by modulating the expression of innate antiviral effector molecules while shaping the antigen-specific CD8+ T cell response.


Zdroje

1. KawaiTAkiraS 2006 Innate immune recognition of viral infection. Nat Immunol 7 131 137

2. HondaKTaniguchiT 2006 IRFs: master regulators of signalling by Toll-like receptors and cytosolic pattern-recognition receptors. Nat Rev Immunol 6 644 658

3. HondaKYanaiHNegishiHAsagiriMSatoM 2005 IRF-7 is the master regulator of type-I interferon-dependent immune responses. Nature 434 772 777

4. LenschowDJLaiCFrias-StaheliNGiannakopoulosNVLutzA 2007 IFN-stimulated gene 15 functions as a critical antiviral molecule against influenza, herpes, and Sindbis viruses. Proc Natl Acad Sci U S A 104 1371 1376

5. DegolsGEldinPMechtiN 2007 ISG20, an actor of the innate immune response. Biochimie 89 831 835

6. SamuelMAWhitbyKKellerBCMarriABarchetW 2006 PKR and RNAse L contribute to protection against lethal West Nile virus infection by controlling early viral spread in the periphery and replication in neurons. J Virol 80 7009 7019

7. ZhangYBurkeCWRymanKDKlimstraWB 2007 Identification and characterization of interferon-induced proteins that inhibit alphavirus replication. J Virol 81 11246 11255

8. BrassALHuangICBenitaYJohnSPKrishnanMN 2009 The IFITM proteins mediate cellular resistance to influenza A H1N1 virus, West Nile virus, and dengue virus. Cell 139 1243 1254

9. DaffisSSzretterKJSchriewerJLiJYounS 2010 2′-O methylation of the viral mRNA cap evades host restriction by IFIT family members. Nature 468 452 456

10. DaffisSSamuelMASutharMSKellerBCGaleMJr 2008 Interferon regulatory factor IRF-7 induces the antiviral alpha interferon response and protects against lethal West Nile virus infection. J Virol 82 8465 8475

11. SejvarJJHaddadMBTierneyBCCampbellGLMarfinAA 2003 Neurologic manifestations and outcome of West Nile virus infection. JAMA 290 511 515

12. BuschMPWrightDJCusterBToblerLHStramerSL 2006 West Nile virus infections projected from blood donor screening data, United States, 2003. Emerg Infect Dis 12 395 402

13. SamuelMADiamondMS 2006 Pathogenesis of West Nile virus infection: A balance between virulence, innate and adaptive immunity, and viral evasion. J Virol 80 9349 9360

14. DiamondMSMehlhopEOliphantTSamuelMA 2009 The host immunologic response to West Nile encephalitis virus. Front Biosci 14 3024 3034

15. SamuelMADiamondMS 2005 Type I IFN protects against lethal West Nile Virus infection by restricting cellular tropism and enhancing neuronal survival. J Virol 79 13350 13361

16. KellerBCFredericksenBLSamuelMAMockREMasonPW 2006 Resistance to alpha/beta interferon is a determinant of West Nile virus replication fitness and virulence. J Virol 80 9424 9434

17. LazearHMPintoAKVogtMRGaleMJrDiamondMS 2011 Interferon-{beta} controls West Nile virus infection and pathogenesis in mice. J Virol 85 7186 7194

18. SutharMSMaDYThomasSLundJMZhangN 2010 IPS-1 is essential for the control of West Nile virus infection and immunity. PLoS Pathog 6 e1000757

19. DaffisSSutharMSSzretterKJGaleMJrDiamondMS 2009 Induction of IFN-beta and the innate antiviral response in myeloid cells occurs through an IPS-1-dependent signal that does not require IRF-3 and IRF-7. PLoS Pathog 5 e1000607

20. FujitaTKimuraYMiyamotoMBarsoumianELTaniguchiT 1989 Induction of endogenous IFN-alpha and IFN-beta genes by a regulatory transcription factor, IRF-1. Nature 337 270 272

21. FujitaTSakakibaraJSudoYMiyamotoMKimuraY 1988 Evidence for a nuclear factor(s), IRF-1, mediating induction and silencing properties to human IFN-beta gene regulatory elements. Embo J 7 3397 3405

22. MiyamotoMFujitaTKimuraYMaruyamaMHaradaH 1988 Regulated expression of a gene encoding a nuclear factor, IRF-1, that specifically binds to IFN-beta gene regulatory elements. Cell 54 903 913

23. PineR 1992 Constitutive expression of an ISGF2/IRF1 transgene leads to interferon-independent activation of interferon-inducible genes and resistance to virus infection. J Virol 66 4470 4478

24. KanazawaNKurosakiMSakamotoNEnomotoNItsuiY 2004 Regulation of hepatitis C virus replication by interferon regulatory factor 1. J Virol 78 9713 9720

25. SchogginsJWWilsonSJPanisMMurphyMYJonesCT 2011 A diverse range of gene products are effectors of the type I interferon antiviral response. Nature 472 481 485

26. SahaBJyothi PrasannaSChandrasekarBNandiD 2010 Gene modulation and immunoregulatory roles of Interferon gamma. Cytokine 50 1 14

27. KimuraTNakayamaKPenningerJKitagawaMHaradaH 1994 Involvement of the IRF-1 transcription factor in antiviral responses to interferons. Science 264 1921 1924

28. KolletJIPetroTM 2006 IRF-1 and NF-kappaB p50/cRel bind to distinct regions of the proximal murine IL-12 p35 promoter during costimulation with IFN-gamma and LPS. Mol Immunol 43 623 633

29. LiuJCaoSHermanLMMaX 2003 Differential regulation of interleukin (IL)-12 p35 and p40 gene expression and interferon (IFN)-gamma-primed IL-12 production by IFN regulatory factor 1. J Exp Med 198 1265 1276

30. LiuJGuanXMaX 2005 Interferon regulatory factor 1 is an essential and direct transcriptional activator for interferon {gamma}-induced RANTES/CCl5 expression in macrophages. J Biol Chem 280 24347 24355

31. Vila-del SolVPunzonCFresnoM 2008 IFN-gamma-induced TNF-alpha expression is regulated by interferon regulatory factors 1 and 8 in mouse macrophages. J Immunol 181 4461 4470

32. DutiaBMAllenDJDysonHNashAA 1999 Type I interferons and IRF-1 play a critical role in the control of a gammaherpesvirus infection. Virology 261 173 179

33. ReisLFRuffnerHStarkGAguetMWeissmannC 1994 Mice devoid of interferon regulatory factor 1 (IRF-1) show normal expression of type I interferon genes. Embo J 13 4798 4806

34. TanakaNIshiharaMKitagawaMHaradaHKimuraT 1994 Cellular commitment to oncogene-induced transformation or apoptosis is dependent on the transcription factor IRF-1. Cell 77 829 839

35. WillmanCLSeverCEPallaviciniMGHaradaHTanakaN 1993 Deletion of IRF-1, mapping to chromosome 5q31.1, in human leukemia and preleukemic myelodysplasia. Science 259 968 971

36. TamuraTIshiharaMLamphierMSTanakaNOishiI 1995 An IRF-1-dependent pathway of DNA damage-induced apoptosis in mitogen-activated T lymphocytes. Nature 376 596 599

37. RomeoGFiorucciGChiantoreMVPercarioZAVannucchiS 2002 IRF-1 as a negative regulator of cell proliferation. J Interferon Cytokine Res 22 39 47

38. TamuraTYanaiHSavitskyDTaniguchiT 2008 The IRF family transcription factors in immunity and oncogenesis. Annu Rev Immunol 26 535 584

39. PenningerJMSirardCMittruckerHWChidgeyAKozieradzkiI 1997 The interferon regulatory transcription factor IRF-1 controls positive and negative selection of CD8+ thymocytes. Immunity 7 243 254

40. MatsuyamaTKimuraTKitagawaMPfefferKKawakamiT 1993 Targeted disruption of IRF-1 or IRF-2 results in abnormal type I IFN gene induction and aberrant lymphocyte development. Cell 75 83 97

41. WhiteLCWrightKLFelixNJRuffnerHReisLF 1996 Regulation of LMP2 and TAP1 genes by IRF-1 explains the paucity of CD8+ T cells in IRF-1-/- mice. Immunity 5 365 376

42. LohoffMFerrickDMittruckerHWDuncanGSBischofS 1997 Interferon regulatory factor-1 is required for a T helper 1 immune response in vivo. Immunity 6 681 689

43. TakiSSatoTOgasawaraKFukudaTSatoM 1997 Multistage regulation of Th1-type immune responses by the transcription factor IRF-1. Immunity 6 673 679

44. KanoSSatoKMorishitaYVollstedtSKimS 2008 The contribution of transcription factor IRF1 to the interferon-gamma-interleukin 12 signaling axis and TH1 versus TH-17 differentiation of CD4+ T cells. Nat Immunol 9 34 41

45. FengCWatanabeSMaruyamaSSuzukiGSatoM 1999 An alternate pathway for type 1 T cell differentiation. Int Immunol 11 1185 1194

46. FragaleAGabrieleLStellacciEBorghiPPerrottiE 2008 IFN regulatory factor-1 negatively regulates CD4+ CD25+ regulatory T cell differentiation by repressing Foxp3 expression. J Immunol 181 1673 1682

47. DaffisSSamuelMAKellerBCGaleMJrDiamondMS 2007 Cell-specific IRF-3 responses protect against West Nile virus infection by interferon-dependent and independent mechanisms. PLoS Pathog 3 e106

48. RamanaCVGilMPSchreiberRDStarkGR 2002 Stat1-dependent and -independent pathways in IFN-gamma-dependent signaling. Trends Immunol 23 96 101

49. AustinBAJamesCSilvermanRHCarrDJ 2005 Critical role for the oligoadenylate synthetase/RNase L pathway in response to IFN-beta during acute ocular herpes simplex virus type 1 infection. J Immunol 175 1100 1106

50. RiosMZhangMJGrinevASrinivasanKDanielS 2006 Monocytes-macrophages are a potential target in human infection with West Nile virus through blood transfusion. Transfusion 46 659 667

51. KongKFWangXAndersonJFFikrigEMontgomeryRR 2008 West nile virus attenuates activation of primary human macrophages. Viral Immunol 21 78 82

52. DeWitte-OrrSJCollinsSEBauerCMBowdishDMMossmanKL 2010 An accessory to the 'Trinity': SR-As are essential pathogen sensors of extracellular dsRNA, mediating entry and leading to subsequent type I IFN responses. PLoS Pathog 6 e1000829

53. SzretterKJDaffisSPatelJSutharMSKleinRS 2010 The innate immune adaptor molecule MyD88 restricts West Nile replication and spread in neurons of the central nervous system. J Virol 84 12125 12138

54. SchroderKHertzogPJRavasiTHumeDA 2004 Interferon-gamma: an overview of signals, mechanisms and functions. J Leukoc Biol 75 163 189

55. SchreiberRDHicksLJCeladaABuchmeierNAGrayPW 1985 Monoclonal antibodies to murine gamma-interferon which differentially modulate macrophage activation and antiviral activity. J Immunol 134 1609 1618

56. ToveyMGLallemandCThyphronitisG 2008 Adjuvant activity of type I interferons. Biol Chem 389 541 545

57. DiamondMSShresthaBMarriAMahanDEngleM 2003 B cells and antibody play critical roles in the immediate defense of disseminated infection by West Nile encephalitis virus. J Virol 77 2578 2586

58. ShresthaBDiamondMS 2004 The role of CD8+ T cells in the control of West Nile virus infection. J Virol 78 8312 8321

59. ShresthaBDiamondMS 2007 Fas Ligand interactions contribute to CD8+ T cell-mediated control of West Nile virus infection in the central nervous system. J Virol 81 11749 11757

60. ShresthaBSamuelMADiamondMS 2006 CD8+ T cells require perforin to clear West Nile virus from infected neurons. J Virol 80 119 129

61. WangYLobigsMLeeEMullbacherA 2003 CD8+ T cells mediate recovery and immunopathology in West Nile virus encephalitis. J Virol 77 13323 13334

62. BrienJDUhrlaubJLNikolich-ZugichJ 2007 Protective capacity and epitope specificity of CD8(+) T cells responding to lethal West Nile virus infection. Eur J Immunol 37 1855 1863

63. LanteriMCO'BrienKMPurthaWECameronMJLundJM 2009 Tregs control the development of symptomatic West Nile virus infection in humans and mice. J Clin Invest 119 3266 3277

64. McCandlessEEZhangBDiamondMSKleinRS 2008 CXCR4 antagonism increases T cell trafficking in the central nervous system and improves survival from West Nile virus encephalitis. Proc Natl Acad Sci U S A 105 11270 11275

65. PlataniasLC 2005 Mechanisms of type-I- and type-II-interferon-mediated signalling. Nat Rev Immunol 5 375 386

66. Garcia-SastreABironCA 2006 Type 1 interferons and the virus-host relationship: a lesson in detente. Science 312 879 882

67. AnkNWestHPaludanSR 2006 IFN-lambda: novel antiviral cytokines. J Interferon Cytokine Res 26 373 379

68. ShresthaBWangTSamuelMAWhitbyKCraftJ 2006 Gamma interferon plays a crucial early antiviral role in protection against West Nile virus infection. J Virol 80 5338 5348

69. WangTScullyEYinZKimJHWangS 2003 IFN-γ-producing γδ T cells help control murine West Nile virus infection. J Immunol 171 2524 2531

70. Azzam-SmoakKNoahDLStewartMJBlumMASherryB 2002 Interferon regulatory factor-1, interferon-beta, and reovirus-induced myocarditis. Virology 298 20 29

71. PurthaWEMyersNMitaksovVSitatiEConnollyJ 2007 Antigen-specific cytotoxic T lymphocytes protect against lethal West Nile virus encephalitis. Eur J Immunol 37 1845 1854

72. EbelGDDupuisAPIIINgoKNicholasDKauffmanE 2001 Partial genetic characterization of West Nile Virus strains, New York State, 2000. Emerg Inf Dis 7 650 653

73. SatoMSuemoriHHataNAsagiriMOgasawaraK 2000 Distinct and essential roles of transcription factors IRF-3 and IRF-7 in response to viruses for IFN-alpha/beta gene induction. Immunity 13 539 548

74. MehlhopEDiamondMS 2006 Protective immune responses against West Nile virus are primed by distinct complement activation pathways. J Exp Med 203 1371 1381

75. FuchsAPintoAKSchwaebleWJDiamondMS 2011 The lectin pathway of complement activation contributes to protection from West Nile virus infection. Virology 412 101 109

76. SzretterKJSamuelMAGilfillanSFuchsAColonnaM 2009 The immune adaptor molecule SARM modulates tumor necrosis factor alpha production and microglia activation in the brainstem and restricts West Nile Virus pathogenesis. J Virol 83 9329 9338

77. ByersAMKemballCCMoserJMLukacherAE 2003 Cutting edge: rapid in vivo CTL activity by polyoma virus-specific effector and memory CD8+ T cells. J Immunol 171 17 21

Štítky
Hygiena a epidemiológia Infekčné lekárstvo Laboratórium

Článok vyšiel v časopise

PLOS Pathogens


2011 Číslo 9
Najčítanejšie tento týždeň
Najčítanejšie v tomto čísle
Kurzy

Zvýšte si kvalifikáciu online z pohodlia domova

Získaná hemofilie - Povědomí o nemoci a její diagnostika
nový kurz

Eozinofilní granulomatóza s polyangiitidou
Autori: doc. MUDr. Martina Doubková, Ph.D.

Všetky kurzy
Prihlásenie
Zabudnuté heslo

Zadajte e-mailovú adresu, s ktorou ste vytvárali účet. Budú Vám na ňu zasielané informácie k nastaveniu nového hesla.

Prihlásenie

Nemáte účet?  Registrujte sa

#ADS_BOTTOM_SCRIPTS#